VistaGen Therapeutics , Inc. – Product Pipeline Review – 2012


December 31, 2012
37 Pages - SKU: GMD4939524
License type:
Table of Contents Search inside this report Related Reports


VistaGen Therapeutics , Inc. – Product Pipeline Review – 2012

Summary

Global Market Direct’s pharmaceuticals report, “VistaGen Therapeutics , Inc. - Product Pipeline Review - 2012” provides data on the VistaGen Therapeutics , Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, VistaGen Therapeutics , Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from VistaGen Therapeutics , Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope
  • VistaGen Therapeutics , Inc. - Brief VistaGen Therapeutics , Inc. overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of VistaGen Therapeutics , Inc. human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of VistaGen Therapeutics , Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of the VistaGen Therapeutics , Inc.’s pipeline in the last quarter.
  • Key discontinued and dormant projects.
  • Latest news and deals relating to the products.
Reasons to buy
  • Evaluate VistaGen Therapeutics , Inc.’s strategic position with total access to detailed information on its product pipeline.
  • Assess the growth potential of VistaGen Therapeutics , Inc. in its therapy areas of focus.
  • Identify new drug targets and therapeutic classes in the VistaGen Therapeutics , Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
  • Exploit collaboration and partnership opportunities with VistaGen Therapeutics , Inc..
  • Avoid Intellectual Property Rights related issues.
  • Explore the dormant and discontinued projects of VistaGen Therapeutics , Inc. and identify potential opportunities in those areas.


VistaGen Therapeutics, Inc. Snapshot
VistaGen Therapeutics, Inc. Overview
Key Information
Key Facts
VistaGen Therapeutics, Inc. – Research and Development Overview
Key Therapeutic Areas
VistaGen Therapeutics, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
VistaGen Therapeutics, Inc. – Pipeline Products Glance
VistaGen Therapeutics, Inc. Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
VistaGen Therapeutics, Inc. – Early Stage Pipeline Products
Discovery Products/Combination Treatment Modalities
VistaGen Therapeutics, Inc. – Drug Profiles
AV-101
Product Description
Mechanism of Action
R&D Progress
Cell Therapy For Cartilage Repair
Product Description
Mechanism of Action
R&D Progress
Cell Therapy For Heart Repair
Product Description
Mechanism of Action
R&D Progress
Cell Therapy For Hematological Disorders
Product Description
Mechanism of Action
R&D Progress
Cell therapy For Liver Repair
Product Description
Mechanism of Action
R&D Progress
VistaGen Therapeutics, Inc. – Pipeline Analysis
VistaGen Therapeutics, Inc. – Pipeline Products by Therapeutic Class
VistaGen Therapeutics, Inc. – Pipeline Products by Route of Administration
VistaGen Therapeutics, Inc. – Pipeline Products By Mechanism of Action
VistaGen Therapeutics, Inc. – Recent Pipeline Updates
VistaGen Therapeutics, Inc. – Locations And Subsidiaries
Head Office
Financial Deals Landscape
VistaGen Therapeutics, Inc., Deals Summary
VistaGen Therapeutics, Inc., Pharmaceuticals & Healthcare, Deal Details
Venture Financing
VistaGen Therapeutics Secured $3.75 Million in Financing
Partnerships
VistaGen Therapeutics Enters Into Research Agreement With Duke University
VistaGen Therapeutics Expands Research And Development Agreement With University Health Network
VistaGen Enters Into Strategic Agreement With Capsant
VistaGen Enters Into Research Agreement With University Health Network and McEwen Centre for Regenerative Medicine
VistaGen Therapeutics Extends Research Agreement With SANWA KAGAKU
Licensing Agreements
VistaGen Therapeutics Enters Into Licensing Agreement With McEwen Centre for Regenerative Medicine
VistaGen Therapeutics Enters Into Licensing Agreement With WARF
VistaGen Therapeutics Enters Into Licensing Agreement With SANWA
Equity Offering
VistaGen Completes Private Placement Of $2.87 Million
Acquisition
Excaliber Completes Acquisition Of VistaGen In Reverse Acquisition
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
VistaGen Therapeutics , Inc., Key Information
VistaGen Therapeutics , Inc., Key Facts
VistaGen Therapeutics , Inc. – Pipeline by Indication, 2012
VistaGen Therapeutics , Inc. – Pipeline by Stage of Development, 2012
VistaGen Therapeutics , Inc. – Monotherapy Products in Pipeline, 2012
VistaGen Therapeutics , Inc. – Phase I, 2012
VistaGen Therapeutics , Inc. – Discovery, 2012
VistaGen Therapeutics , Inc. – Pipeline By Therapeutic Class, 2012
VistaGen Therapeutics , Inc. – Pipeline By Route of Administration, 2012
VistaGen Therapeutics , Inc. – Pipeline Products By Mechanism of Action, 2012
VistaGen Therapeutics , Inc. – Recent Pipeline Updates, 2012
VistaGen Therapeutics , Inc., Deals Summary
VistaGen Therapeutics Secured $3.75 Million in Financing
VistaGen Therapeutics Enters Into Research Agreement With Duke University
VistaGen Therapeutics Expands Research And Development Agreement With University Health Network
VistaGen Enters Into Strategic Agreement With Capsant
VistaGen Enters Into Research Agreement With University Health Network and McEwen Centre for Regenerative Medicine
VistaGen Therapeutics Extends Research Agreement With SANWA KAGAKU
VistaGen Therapeutics Enters Into Licensing Agreement With McEwen Centre for Regenerative Medicine
VistaGen Therapeutics Enters Into Licensing Agreement With WARF
VistaGen Therapeutics Enters Into Licensing Agreement With SANWA
VistaGen Completes Private Placement Of $2.87 Million
Excaliber Completes Acquisition Of VistaGen In Reverse Acquisition
List of Figures
VistaGen Therapeutics , Inc. – Pipeline by Indication, 2012
VistaGen Therapeutics , Inc. – Pipeline by Stage of Development, 2012
VistaGen Therapeutics , Inc. – Monotherapy Products in Pipeline, 2012
VistaGen Therapeutics , Inc. – Pipeline By Therapeutic Class, 2012

More V - Companies reports by Global Markets Direct

Verva Pharmaceuticals Limited – Product Pipeline Review – 2012 by Global Markets Direct
Verva Pharmaceuticals Limited – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Verva Pharmaceuticals Limited - Product Pipeline Review - 2012” provides data on ...
Viralytics Ltd. – Product Pipeline Review – 2012 by Global Markets Direct
Viralytics Ltd. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Viralytics Ltd. - Product Pipeline Review - 2012” provides data on the Viralytics ...
Vyteris, Inc. – Product Pipeline Review – 2012 by Global Markets Direct
Vyteris, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Vyteris, Inc. - Product Pipeline Review - 2012” provides data on the Vyteris, ...
VIA Pharmaceuticals, Inc. – Product Pipeline Review – 2012 by Global Markets Direct
VIA Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “VIA Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on ...
See all reports like this >>

 

Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Related Markets


V - Companies Reports

 
 

Share this report


Other tasks

 
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!